Techbio Today

The front page of AI-driven biology

Publications

Newly published peer-reviewed research across journals and publishers, with the original publication date and what was actually tested.

  • Upgraded diffusion model scaffolds intricate enzyme active sites from scratch

    University of Washington researchers have introduced RFdiffusion3, a generative model that uses free-atom diffusion to build custom protein and RNA structures around precise geometric constraints. Tested across functional enzyme challenges, the system designed synthetic phosphotriesterases that coordinate two metal ions and zinc-dependent proteases tailored to cut transthyretin, a protein implicated in amyloid diseases. Both enzyme campaigns yielded functional catalysts without iterative rounds of laboratory optimization, producing active hits within 96 tested candidates.

    Science
  • Language models pull standardized rare-disease symptoms directly from patient notes

    Researchers built RARE-PHENIX, an automated framework that reads unstructured clinical text, standardizes symptoms into formal Human Phenotype Ontology terms, and ranks them by diagnostic importance. The pipeline was trained on records from 2,671 patients across 11 clinical sites in the Undiagnosed Diseases Network, then tested on 16,357 notes from 143 patients at Vanderbilt University Medical Center. The extracted phenotype lists matched clinician curation closely and preserved signal for downstream disease-prioritization tools.

    npj Digital Medicine
  • Unified variant caller improves structural mutation detection across short- and long-read data

    HitSV combines repeat-aware breakpoint detection with haplotype-resolved local DNA assembly to identify structural genomic variants across multiple sequencing platforms. In evaluations on the reference human genome HG002 benchmark, the algorithm improved genotype F1 scores by up to 72% on long-read data and up to 36% on short-read sequences compared to existing tools. Applied to the 1000 Genomes Project phase 4 cohort, the method expanded the catalog of detected structural variants by 31.5%, uncovering widespread composite repeat arrays in human populations.

    Nature Biotechnology

Send feedback